Paraneoplastic proteinuria in papillary renal cell carcinoma; a case report

Fatemeh Yaghoubi ¹, Maliheh Yarmohammadi ² * , Mohammad Vasei ³

Cited by CrossRef: 4

1- Zhang X, Khurana A, Hirani S, Kidd J, Paul A. Paraneoplastic Glomerulonephropathy Associated With Renal Cell Carcinoma: A Descriptive Analysis of Published Reports. 2023; [Crossref]

2- Singh Singh A, Naranjo J, Alonso M, Villanego F, Amaro J, Carrasco D, Salvatierra C, Mazuecos A. Successful treatment of renal cell carcinoma with paraneoplastic nephrotic syndrome: a case report. Front Med. 2025;12 [Crossref]

3- Okada A, Higashihara T, Kusano , Takemura , Saigusa H, Maruno S, Matsumura M, Suzuki T, Shimizu A, Takano H. IL-6-producing Renal Cell Carcinoma Causing Renal and Endocrine Paraneoplastic Syndromes. Intern Med. 2019;58(13):1953 [Crossref]

4- Trevisani F, Floris M, Vago R, Minnei R, Cinque A. Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?. Cells. 2022;11(10):1658 [Crossref]

5- Daanen R, Maas R, Koornstra R, Steenbergen E, van Herpen C, Willemsen A. Nivolumab-associated Nephrotic Syndrome in a Patient With Renal Cell Carcinoma: A Case Report. 2017;40(9):345 [Crossref]